Frank Yocca Net Worth & Insider Trades
Frank Yocca - Chief Scientific Officer, Bioxcel Therapeutics, Inc
What is Frank Yocca's Net Worth?
The current estimated net worth of Bioxcel Therapeutics, Inc's Chief Scientific Officer, Frank Yocca, is estimated to be about $6.45M . Frank Yocca owns about 9,496 units of Bioxcel Therapeutics, Inc common stock. In the last 5 years at Bioxcel Therapeutics, Inc, Frank Yocca has sold an estimated value of $3.84M worth.
What is Frank Yocca's Past Insider Trading?
Frank Yocca's largest purchase order was 6,547 units , worth over $56.76K on August 14, 2019. Frank Yocca's largest sale order was 50,000 units , worth over $1.5M on January 24, 2023. In total, Frank Yocca has made about 14 transactions over 5 years of their time at Bioxcel Therapeutics, Inc. Frank Yocca usually trades in March, with the busiest year in 2018 and 2021. The most recent transaction was a sale order of 985 units , worth over $19.4K on March 16, 2023.
Frank Yocca
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Frank Yocca's' Mailing Address?
- Mailing address is 780 East Main Street C/o Bioxcel Therapeutics, Inc. Branford CT 06405 CT
Bioxcel Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Vimal Mehta, Ph.D. | 2020 | $890,000 | - | $8,122,500 | $556,250 | $7,800 | $9,576,550 |
| Vimal Mehta, Ph.D. | 2019 | $459,000 | - | $1,269,131 | $233,000 | $7,800 | $1,968,931 |
| William P. Kane, Jr. | 2020 | $245,455 | - | $4,185,500 | $138,699 | - | $4,569,654 |
| Reina Benabou, M.D., Ph.D. | 2020 | $197,443 | - | $2,462,400 | $76,341 | - | $2,736,184 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1720893/000110465921055605/tm212482-3_def14a.htm
What are Bioxcel Therapeutics, Inc's Past Insider Trades?
Bioxcel Therapeutics, Inc's most recent insider trade came on March 22, 2023 by Vimal Mehta who sold 64,500 units worth $1.22M . In the last 5 years, insiders at Bioxcel Therapeutics, Inc have sold an estimated value of $138.54M and bought an estimated value of $20.07M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Vimal Mehta, CEO and President, Frank Yocca, Chief Scientific Officer, and Peter Mueller, Director .
BioXcel Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||